Today: 21 May 2026
AMD stock slides as Big Tech’s AI spending boom meets fresh nerves on Wall Street
29 January 2026
1 min read

AMD stock slides as Big Tech’s AI spending boom meets fresh nerves on Wall Street

New York, January 29, 2026, 10:27 (EST) — Regular session

Advanced Micro Devices shares slipped 1.6% to $248.59 in Thursday morning trading, retreating from an earlier peak of $260.22. The stock lost $4.15 compared to its previous close.

The shift happened as U.S. tech shares took a hit. The Nasdaq dropped roughly 1% early on, dragged lower by Microsoft, which stumbled after cloud revenue missed expectations. That fueled fresh doubts about whether hefty AI investments are paying off quickly enough.

This debate hits home for AMD, whose chips power the servers behind AI. Capital expenditures on data centers and gear — or “capex” — are the key variable. Anthony Saglimbene, chief market strategist at Ameriprise Financial, said investors are looking for “very visible monetization or earnings.” Reuters

Microsoft’s figures added to the jitters. Shares dropped in Europe after the company revealed it poured a record sum into AI last quarter and reported slower growth in cloud computing, spooking investors fixated on short-term gains.

Meta shifted gears, raising its 2026 capital expenditure outlook to $115 billion-$135 billion amid its drive toward “superintelligence,” CEO Mark Zuckerberg told analysts. CFO Susan Li warned that capacity constraints will likely persist through much of 2026. Reuters

Chip shares surged the previous day on a growing AI wave. Positive cues from Texas Instruments and others pushed several names up. AMD, Nvidia, and Intel all gained as investors wagered that data-center demand is expanding past Nvidia’s top-tier processors.

Thursday saw a cooler mood across the sector. Nvidia slipped 1.6% to $188.48, while Intel dropped roughly 1.5%, closing at $48.05. AMD stayed roughly in line with the group’s movement.

But sentiment can shift fast. Software shares dropped following SAP’s cautious forecast for its cloud business and a sell-off in ServiceNow. Adam Turnquist of LPL Financial noted the market appears to be pricing in a “worst case scenario” — basically that “software is dead” as AI shakes up the sector. Reuters

AMD’s next major event is right around the corner. The company will release its fiscal fourth-quarter and full-year 2025 results after the market closes on Feb. 3, followed by a 5:00 p.m. EST conference call. CTO Mark Papermaster is also set to appear at Morgan Stanley’s Technology, Media & Telecom Conference on March 3.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Bitcoin tumbles below $87,000 as Fed pause and ETF outflows keep crypto on the back foot
Previous Story

Bitcoin tumbles below $87,000 as Fed pause and ETF outflows keep crypto on the back foot

Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens
Next Story

Dow Jones today: DJIA edges up near 49,000 as AI spending scrutiny deepens

Go toTop